ClinicalTrials.gg
Sign In

Coronaviridae Infections clinical trials

The registry lists 28 studies for Coronaviridae Infections across more than 10 countries. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-15. Counting its 4 narrower conditions too, such as COVID-19: 8,802 studies, 638 open.

Get an email when these change. Save the Coronaviridae Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
20
Recruiting
3
Terminated
2
Active, not recruiting
1
Withdrawn
1
Suspended
1

Phase

Phase 3
17
Phase 2
6
Phase 4
2
Phase 1
1

Where

United States
23
Denmark
8
Spain
8
Singapore
7
Uganda
6
Switzerland
6

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (12) · BioNTech SE (3) · Assistance Publique - Hôpitaux de Paris (2) · Pfizer (2) · Adrian Hernandez (1) · Dalarna County Council, Sweden (1) · ProgenaBiome (1) · Grifols Therapeutics LLC (1)

What is being tested here

Drugs under test in Coronaviridae Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
BNT162 Vaccine223
Ibuzatrelvir111
Bamlanivimab033
Remdesivir022
Aviptadil022
Amubarvimab022
Romlusevimab022
Ensovibep022
Sotrovimab022
Lufotrelvir022

Coming up

2phase 3 studies under way
3studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 3 Coronaviridae Infections studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 2 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (67%) take healthy volunteers.

Recruiting studies that take each age, of 3
AgeWomenMen
101 (33%)1 (33%)
183 (100%)3 (100%)
303 (100%)3 (100%)
403 (100%)3 (100%)
503 (100%)3 (100%)
652 (67%)2 (67%)
752 (67%)2 (67%)
852 (67%)2 (67%)

Across all 28 studies, recruiting or not: 11% stop at 75 or younger and 7% at 65; 14% take children; 0% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Coronaviridae Infections studies take

Of 15 phase 3 interventional studies under Coronaviridae Infections, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 38 mo5–16 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 28 of 28. search them.